# Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

> **NCT07116694** · PHASE2 · COMPLETED · sponsor: **BioXcel Therapeutics Inc** · enrollment: 33 (actual)

## Conditions studied

- Bipolar I Disorder
- Bipolar II Disorder
- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorders
- Psychomotor Agitation

## Interventions

- **DRUG:** BXCL501 Sublingual Film

## Key facts

- **NCT ID:** NCT07116694
- **Lead sponsor:** BioXcel Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-19
- **Primary completion:** 2025-10-07
- **Final completion:** 2025-10-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116694, "Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07116694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*